Friday, 17 August 2018

Biocon receives EU approval for Biosimilar facility

05 July 2018 | News

The Sterile Drug Product manufacturing facility in Bengaluru was inspected by the European agencies in March 2018.

Biocon Ltd, Asia’s premier biopharmaceutical company, has announced that it has received the EU GMP certification for its Sterile Drug Product manufacturing facility in Bengaluru, which was inspected by the European agencies in March 2018.

This facility is used for the manufacturing of Biocon’s portfolio of biosimilars.  Biocon remains committed to global standards of quality and compliance.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Will government's drug price caps trigger showdown with US?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls